Polymyxin B nonapeptide potentiates the eradication of Gram-negative bacterial persisters
Microbiology Spectrum · 02.04.2024 · 12 (4)
DOI: 10.1128/spectrum.03687-23 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbiology Spectrum, erschienen am 02.04.2024. Verfasst von Sun Ju Kim und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Sungkyunkwan University, Suwon, Republic of Korea. Hauptthemen laut MEDLINE: Bacterial Infections, Gram-Negative Bacterial Infections. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea (NRF).
Abstract (Originalsprache)
Antibiotic-resistant Gram-negative bacteria remain a globally leading cause of bacterial infection-associated mortality, and it is imperative to identify novel therapeutic strategies. Recently, the advantage of using antibacterials selective against Gram-negative bacteria has been demonstrated with polymyxins that specifically target the lipopolysaccharides of Gram-negative bacteria. However, the severe cytotoxicity of polymyxins limits their clinical use. Here, we demonstrate that polymyxin B nonapeptide (PMBN), a polymyxin B derivative without the terminal amino acyl residue, can significantly enhance the effectiveness of commonly used antibiotics against only Gram-negative bacteria and their persister cells. We show that although PMBN itself does not exhibit antibacterial activity or cytotoxicity well above the 100-fold minimum inhibitory concentration of polymyxin B, PMBN can increase the potency of co-treated antibiotics. We also demonstrate that using PMBN in combination with other antibiotics significantly reduces the frequency of resistant mutant formation. Together, this work provides evidence of the utilities of PMBN as a novel potentiator for antibiotics against Gram-negative bacteria and insights for the eradication of bacterial persister cells during antibiotic treatment. IMPORTANCE The significance of our study lies in addressing the problem of antibiotic-resistant Gram-negative bacteria, which continue to be a global cause of mortality associated with bacterial infections. Therefore, identifying innovative therapeutic approaches is an urgent need. Recent research has highlighted the potential of selective antibacterials like polymyxins, which specifically target the lipopolysaccharides of Gram-negative bacteria. However, the clinical use of polymyxins is limited by their severe cytotoxicity. This study unveils the effectiveness of polymyxin B nonapeptide (PMBN) in significantly enhancing the eradication of persister cells in Gram-negative bacteria. Although PMBN itself does not exhibit antibacterial activity or cytotoxicity, it remarkably reduces persister cells during the treatment of antibiotics. Moreover, combining PMBN with other antibiotics reduces the emergence of resistant mutants. Our research emphasizes the utility of PMBN as a novel potentiator to decrease persister cells during antibiotic treatments for Gram-negative bacteria.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Sungkyunkwan University, Suwon, Republic of Korea.
- Department of Microbiology, School of Medicine, Sungkyunkwan University, Suwon, Republic of Korea.
ORCID-Profile: Sun Ju Kim, Kwan Soo Ko, Wonsik Lee
Förderung
- National Research Foundation of Korea (NRF)
Zitieren
APA
Kim, S. J., Jo, J., Kim, J., Ko, K. S., & Lee, W. (2024). Polymyxin B nonapeptide potentiates the eradication of Gram-negative bacterial persisters. Microbiology Spectrum, 12(4). https://doi.org/10.1128/spectrum.03687-23
Vancouver
Kim SJ, Jo J, Kim J, Ko KS, Lee W. Polymyxin B nonapeptide potentiates the eradication of Gram-negative bacterial persisters. Microbiology Spectrum. 2024;12(4). doi:10.1128/spectrum.03687-23
BibTeX
@article{Kim2024,
author = {Kim, Sun Ju and Jo, Jeongwoo and Kim, Jihyeon and Ko, Kwan Soo and Lee, Wonsik},
title = {Polymyxin B nonapeptide potentiates the eradication of Gram-negative bacterial persisters},
journal = {Microbiology Spectrum},
year = {2024},
volume = {12},
number = {4},
doi = {10.1128/spectrum.03687-23}
}
EUVIMED